An edition of Committee staff report to the chairman and ranking member
(2006)
Committee staff report to the chairman and ranking member
review of the FDA's approval process for the vagus nerve stimulation therapy system for treatment-resistant depression
by United States. Congress. Senate. Committ...
Share
×Close
This edition doesn't have a description yet. Can you add one?
Check nearby libraries
Buy this book
Subjects
United States, Government policy, Treatment, Rules and practice, Mental Depression, Therapeutic use, Transcutaneous electrical nerve stimulation, Vagus nerve, United States. Food and Drug Administration, United states, food and drug administration, Depression, mental, Mental illness, treatment, AnalgesiaPlaces
United States| Edition | Availability |
|---|---|
1
Committee staff report to the chairman and ranking member: review of the FDA's approval process for the vagus nerve stimulation therapy system for treatment-resistant depression
2006, U.S. G.P.O., For sale by the Supt. of Docs., U.S. G.P.O.
in English
0160758777 9780160758775
|
aaaa
|
Book Details
Edition Notes
At head of title: 109th Congress, 2d session, Committee print
"Printed for the use of the Committee on Finance."
Distributed to some depository libraries in microfiche
Shipping list no.: 2006-0141-P
Includes bibliographical references
Also available via Internet from the Finance Committee web site. Address as of 4/27/06: http://finance.senate.gov/press/Gpress/02%5F2006%20report.pdf; current access available via PURL
Classifications
The Physical Object
ID Numbers
Community Reviews (0)
Feedback?
| January 31, 2024 | Edited by ImportBot | import existing book |
| February 7, 2019 | Created by MARC Bot | import existing book |